Quantitative profiling of the protein coronas that form around nanoparticles
暂无分享,去创建一个
Stefan Tenzer | Ute Distler | Jörg Kuharev | S. Tenzer | Ute Distler | Jörg Kuharev | R. Stauber | S. Knauer | D. Docter | A. Hahlbrock | Dominic Docter | W. Storck | D. Wünsch | Shirley K Knauer | Roland H Stauber | Wiebke Storck | Angelina Hahlbrock | Desirée Wünsch | Angelina Hahlbrock
[1] Morteza Mahmoudi,et al. Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles. , 2011, ACS nano.
[2] Iseult Lynch,et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.
[3] Morteza Mahmoudi,et al. Engineered nanoparticles for biomolecular imaging. , 2011, Nanoscale.
[4] James L. McGrath,et al. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. , 2009, Biomaterials.
[5] Konstantinos Thalassinos,et al. A comparison of labeling and label-free mass spectrometry-based proteomics approaches. , 2009, Journal of proteome research.
[6] Stefan Tenzer,et al. Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics , 2013, Nature Methods.
[7] Raimo Hartmann,et al. Temperature: the "ignored" factor at the NanoBio interface. , 2013, ACS nano.
[8] Phillip C. Wright,et al. An insight into iTRAQ: where do we stand now? , 2012, Analytical and Bioanalytical Chemistry.
[9] R. von Klitzing,et al. Impact of polymer shell on the formation and time evolution of nanoparticle-protein corona. , 2013, Colloids and surfaces. B, Biointerfaces.
[10] S. K. Sundaram,et al. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[11] Marina A Dobrovolskaia,et al. Evaluation of nanoparticle immunotoxicity. , 2009, Nature nanotechnology.
[12] Philip M. Kelly,et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.
[13] R. Müller,et al. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[14] Sara Linse,et al. Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid , 2010, PloS one.
[15] Giulio Caracciolo,et al. DNA affects the composition of lipoplex protein corona: A proteomics approach , 2011, Proteomics.
[16] Giulio Caracciolo,et al. Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery. , 2013, Langmuir : the ACS journal of surfaces and colloids.
[17] R. Aebersold,et al. A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas* , 2011, Molecular & Cellular Proteomics.
[18] Kenneth A. Dawson,et al. Nanobiotechnology: Nanoparticle coronas take shape , 2011 .
[19] Marco P Monopoli,et al. Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.
[20] Iseult Lynch,et al. What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.
[21] Jack F Douglas,et al. Interaction of gold nanoparticles with common human blood proteins. , 2010, ACS nano.
[22] Albert Duschl,et al. Time evolution of the nanoparticle protein corona. , 2010, ACS nano.
[23] Birgit Sokull-Klüttgen,et al. The European Commission's recommendation on the definition of nanomaterial makes an impact , 2012, Nanotoxicology.
[24] W. Peukert,et al. Impact of the nanoparticle-protein corona on colloidal stability and protein structure. , 2012, Langmuir : the ACS journal of surfaces and colloids.
[25] S. Seal,et al. Fabricated micro-nano devices for in vivo and in vitro biomedical applications. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[26] T. Xia,et al. Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.
[27] Morteza Mahmoudi,et al. Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. , 2011, Nanoscale.
[28] Ronald J. Moore,et al. Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size , 2011, Proteomics.
[29] K. Dawson,et al. Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. , 2007, Nano letters.
[30] Shuk Han Cheng,et al. Characterization of carbon nanotube protein corona by using quantitative proteomics. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[31] R. Müller,et al. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. , 2005, Biomaterials.
[32] T. Webster. Interview: Nanomedicine: past, present and future. , 2013, Nanomedicine.
[33] Stefan Tenzer,et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. , 2011, ACS nano.
[34] L. Gethings,et al. Simplifying the proteome: analytical strategies for improving peak capacity. , 2014, Advances in experimental medicine and biology.
[35] Bernhard Kuster,et al. Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present , 2012, Analytical and Bioanalytical Chemistry.
[36] Brett Larsen,et al. Label-free quantitative proteomics trends for protein-protein interactions. , 2013, Journal of proteomics.
[37] P. Chakrabarti,et al. Contrasting effect of gold nanoparticles and nanorods with different surface modifications on the structure and activity of bovine serum albumin. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[38] Iseult Lynch,et al. The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.
[39] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[40] Parag Aggarwal,et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[41] Niko Hildebrandt,et al. Quantum-dot-basedFörster resonance energy transfer immunoassay for sensitive clinical diagnostics of low-volume serum samples. , 2013, ACS nano.
[42] Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model , 2013, Alzheimer's Research & Therapy.
[43] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[44] Michelle Reese. Nanotechnology: using co-regulation to bring regulation of modern technologies into the 21st century. , 2013, Health matrix.
[45] G. Oberdörster,et al. Nanotoxicology: in Vitro–in Vivo Dosimetry , 2012, Environmental health perspectives.
[46] Jim E Riviere,et al. An index for characterization of nanomaterials in biological systems. , 2010, Nature nanotechnology.
[47] Stefan Tenzer,et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.
[48] Sara Linse,et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.
[49] Knut Reinert,et al. Tools for Label-free Peptide Quantification , 2012, Molecular & Cellular Proteomics.
[50] Bengt Fadeel,et al. Safety assessment of nanomaterials: implications for nanomedicine. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[51] R. Müller,et al. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[52] Wolfgang J Parak,et al. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. , 2009, Nature nanotechnology.